Ultime notizie per AptarGroup (NYSE:ATR) Azioni

AptarGroup

Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

Ecco cosa osservano gli analisti e quali potrebbero essere le opportunità per gli investitori questo mese.

Scopri i 3 titoli del settore dei materiali che potrebbero esplodere questo mese

AptarGroup Inc

Atara Biotherapeutics, Inc. - Common Stock

Atara Biotherapeutics Inc

AtriCure Inc

Atrion Corp

Atari Token

Astronics Corp

Altarea SCA

Altius Renewable Royalties Corp Ordinary Shares

ADHERA THERAPEUTICS INC by Adhera Therapeutics Inc.

Adhera Therapeutics Inc

Wells Fargo analyst Gabe Hajde maintains AptarGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) with a Overweight and raises the price target from $170 to $173.

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on AptarGroup, Raises Price Target to $173

Aptar Pharma, a global leader in drug delivery and active material science solutions and services, today announces its acquisition of the clinical trial materials manufacturing capabilities of Mod3 Pharma (formerly Enteris Biopharma) from SWK Holdings. This strategic move strengthens Aptar's support for early-stage drug development by offering formulation, fill and finish services for Phase 1 and 2 clinical trials and enhances adoption of its proprietary devices in early-stage clinical programs.
This acquisition builds on a successful collaboration between Aptar Pharma and Mod3 Pharma, particularly in serving Aptar Pharma customers with Phase 1 and Phase 2 cGMP fill and finish services for orally inhaled nasal drug products (OINDPs), filling a largely unmet need in the market. The capabilities acquired also help Aptar address a growing market demand for agile, high-quality Current Good Manufacturing Practices (cGMP) clinical trial material supply services that complement the segment's existing service offerings. Additionally, the acquisition accelerates the adoption of new drug delivery technologies, initially focusing on OINDPs, with potential expansion into dermal, ophthalmic, injectable and secondary packaging solutions using Aptar's Active Material Science Solutions.
Aptar Pharma will now operate an FDA-inspected, state-of-the-art facility in Boonton, New Jersey. The site includes cGMP cleanrooms, high-potency Active Pharmaceutical Ingredient (API) suites, biologics capabilities, and advanced fill-finish technologies - fully aligned with Aptar Pharma's drug delivery solutions portfolio.
Gael Touya, President of Aptar Pharma, commented, "Our vision at Aptar Pharma is clear: From formulation to patient. By integrating Phase 1 and 2 clinical manufacturing capabilities, we're not just expanding our technical footprint - we're deepening our commitment to customers seeking a seamless and accelerated path to market. This move reinforces our position as a trusted partner from molecule to delivery, and ultimately, to the patient."
Sai Shankar, President, M&amp;A, Strategy, Business Development, Marketing, Drug Services, added, "We're expanding our niche services to help customers move faster in areas of unmet need, and without duplicating the strengths of our trusted partners. This strategic expansion of our services builds on our legacy in drug dosing and dispensing systems by integrating deeper expertise as a drug delivery innovator, as well as product development and formulation, allowing us to offer more specialized and holistic support to our customers."
Dr. Paul Shields, CEO of Mod3 Pharma, remarked, "We are delighted to become part of the Aptar family. This acquisition reflects our shared commitment of accelerating the development of innovative therapies and bringing them to patients faster."

General

AptarGroup's Aptar Pharma Acquires The Clinical Trial Materials Manufacturing Capabilities Of Mod3 Pharma From SWK Holdings; Terms Not Disclosed

Raymond James analyst Matt Roberts maintains AptarGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) with a Outperform and raises the price target from $175 to $182.

Raymond James Maintains Outperform on AptarGroup, Raises Price Target to $182

Dual-active material science solution is ideal for sensitive formulations
AptarGroup, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has developed a dual-active material science technology engineered to simultaneously control moisture and oxygen. This technology is designed to provide a singular solution to address these degradation drivers for pharmaceutical drugs, including oral solid dose glucagon-like peptide-1 (GLP-1), medical devices and more.
This new solution marks a significant material science breakthrough in the pharmaceutical industry, extending Aptar CSP Technologies' <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Faptar.com%2Fproducts%2Fpharmaceutical%2F3-phase-activ-polymer-technology%2F&amp;esheet=54285423&amp;newsitemid=20250708320370&amp;lan=en-US&amp;anchor=3-Phase+Activ-Polymer%26%238482%3B+technology&amp;index=1&amp;md5=2b581606d873326b8f07f68859781d59">3-Phase Activ-Polymer&#x2122; technology</a> into new use cases where a combination of humidity and oxidation can compromise the efficacy, safety, and shelf life of sensitive oral solid dose drugs, medical devices, implantable mesh devices, microarray patches and transdermal delivery systems.

Biotech

Aptar Unveils Dual-Active Material Science Technology To Protect Sensitive Pharma And Medical Devices From Moisture And Oxygen

AptarGroup's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) short percent of float has fallen 7.41% since its last report. The company recently reported that it has 874 thousand shares sold short, which is 1.5% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.13 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>AptarGroup Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751900431_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for AptarGroup has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing AptarGroup's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, AptarGroup's peer group average for short interest as a percentage of float is 4.62%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Looking Into AptarGroup's Recent Short Interest

AptarGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) has outperformed the market over the past 20 years by 1.05% on an annualized basis producing an average annual return of 9.53%. Currently, AptarGroup has a market capitalization of $10.58 billion. 
Buying $100 In ATR: If an investor had bought $100 of ATR stock 20 years ago, it would be worth $624.91 today based on a price of $160.32 for ATR at the time of writing.
<h3>AptarGroup's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751494511_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In AptarGroup 20 Years Ago Would Be Worth This Much Today

AptarGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) has outperformed the market over the past 20 years by 1.01% on an annualized basis producing an average annual return of 9.36%. Currently, AptarGroup has a market capitalization of $9.88 billion. 
Buying $100 In ATR: If an investor had bought $100 of ATR stock 20 years ago, it would be worth $607.92 today based on a price of $149.70 for ATR at the time of writing.
<h3>AptarGroup's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750351512_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning AptarGroup Stock In The Last 20 Years

AptarGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) has outperformed the market over the past 20 years by 1.16% on an annualized basis producing an average annual return of 9.49%. Currently, AptarGroup has a market capitalization of $10.06 billion. 
Buying $100 In ATR: If an investor had bought $100 of ATR stock 20 years ago, it would be worth $622.93 today based on a price of $152.49 for ATR at the time of writing.
<h3>AptarGroup's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749223825_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In AptarGroup 20 Years Ago Would Be Worth Today

AptarGroup's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) short percent of float has risen 32.0% since its last report. The company recently reported that it has 964 thousand shares sold short, which is 1.65% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.72 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>AptarGroup Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747850470_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for AptarGroup has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing AptarGroup's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, AptarGroup's peer group average for short interest as a percentage of float is 4.19%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into AptarGroup's Recent Short Interest

Wells Fargo analyst Gabe Hajde maintains AptarGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) with a Overweight and raises the price target from $162 to $170.

Wells Fargo Maintains Overweight on AptarGroup, Raises Price Target to $170

AptarGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) reported quarterly earnings of $1.20 per share which beat the analyst consensus estimate of $1.16 by 3.45 percent. This is a 1.64 percent decrease over earnings of $1.22 per share from the same period last year. The company reported quarterly sales of $887.30 million which missed the analyst consensus estimate of $898.63 million by 1.26 percent. This is a 3.07 percent decrease over sales of $915.45 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

AptarGroup Q1 Adj. EPS $1.20 Beats $1.16 Estimate, Sales $887.30M Miss $898.63M Estimate

AAMI

AAPL

ABNB

ACCO

ADPT

AGCO

AGIO

ALHC

ALKS

ALNY

ALSN

AMGN

AMWL

AMZN

APLE

APTV

ARDX

ARVN

ASND

ASPS

ASUR

ATEC

ATEN

AXTI

BBAI

BIIB

BJRI

BLDR

BMRN

BOOM

BPMC

BRFH

CABO

CARR

CART

CERS

CMLS

COHN

COHU

COLM

COMM

COOK

CRAI

CTRE

CUBE

CWST

DBRG

DINO

DSGR

DUOL

DXCM

ECVT

ELME

Earnings Scheduled For May 1, 2025

Raymond James analyst Matt Roberts maintains AptarGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) with a Outperform and lowers the price target from $190 to $175.

Raymond James Maintains Outperform on AptarGroup, Lowers Price Target to $175

Aptar Commences Clinical Validation Study Of Its SmartTrack In-Vitro-in-Silico Platform For Pressurized Metered-Dose Inhalers

AptarGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) has outperformed the market over the past 20 years by 1.09% on an annualized basis producing an average annual return of 9.0%. Currently, AptarGroup has a market capitalization of $9.93 billion. 
Buying $100 In ATR: If an investor had bought $100 of ATR stock 20 years ago, it would be worth $563.42 today based on a price of $150.53 for ATR at the time of writing.
<h3>AptarGroup's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743689768_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

AptarGroup's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) short percent of float has risen 25.24% since its last report. The company recently reported that it has 756 thousand shares sold short, which is 1.29% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.9 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>AptarGroup Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742931914_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for AptarGroup has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing AptarGroup's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, AptarGroup's peer group average for short interest as a percentage of float is 4.37%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

What's Driving the Market Sentiment Around AptarGroup?

AptarGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) has outperformed the market over the past 20 years by 1.15% on an annualized basis producing an average annual return of 9.2%. Currently, AptarGroup has a market capitalization of $10.14 billion. 
Buying $1000 In ATR: If an investor had bought $1000 of ATR stock 20 years ago, it would be worth $5,819.89 today based on a price of $152.50 for ATR at the time of writing.
<h3>AptarGroup's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741709709_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

AptarGroup's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) short percent of float has risen 14.44% since its last report. The company recently reported that it has 604 thousand shares sold short, which is 1.03% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.16 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>AptarGroup Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741007718_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for AptarGroup has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing AptarGroup's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, AptarGroup's peer group average for short interest as a percentage of float is 4.24%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About AptarGroup?

Each week,&nbsp;Benzinga&#8217;s Stock Whisper Index&nbsp;uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the&nbsp;<a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">surface and deserve attention</a>.
Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance of information to uncover new opportunities and understand why certain stocks should be of interest.
Read Also:&nbsp;<a href="https://www.benzinga.com/trading-ideas/25/01/42802731/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-2024-where-do-tesla-nvidia-gamestop-trump-media-stocks-rank" target="_blank" rel="noreferrer noopener">EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In 2024 — Where Do Tesla, Nvidia, GameStop, Trump Media Stocks Rank?</a>
Here's a look at the Benzinga Stock Whisper Index for the week ending Feb. 21:
 Sempra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRE#NYSE">SRE</a>): The utility company saw an increase of interest from Benzinga readers during the week. The company will report fourth-quarter financial results next week. Analysts expect the company to report earnings per share of $1.60, up from $1.13 in last year's fourth quarter according to data <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022125&amp;t=be2bearmibe3na1">from Benzinga Pro. </a>The company has missed analyst estimates for earnings per share in two straight quarters, while beating in eight of the last 10 quarters overall. Analysts expect the company to report fourth-quarter revenue of $4.36 billion. The company has missed analyst estimates in six straight quarters and seven of the last 10 quarters overall. Sempra's report could be followed closer than normal given the company's presence in the California market where<a href="https://www.benzinga.com/25/01/42899953/five-dead-in-los-angeles-wildfires-utilities-face-scrutiny"> wildfires took place.</a>
The stock was up around 3% for the week, as seen in the <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022125&amp;t=be2bearmibe3na1">Benzinga Pro chart </a>below. Shares are up 21% over the last year.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022125&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1001" height="464" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21171734/Screenshot-334.png" alt="" class="wp-image-793864" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21171734/Screenshot-334.png 1001w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21171734/Screenshot-334-300x139.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21171734/Screenshot-334-768x356.png 768w" sizes="(max-width: 1001px) 100vw, 1001px" /></a></figure>
Vistra Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>): Investors paid close attention to the energy company this week, which has been a top performing stock over the last year. With ties to the nuclear energy business, the stock has soared and is up over 200% in the last year. JPMorgan <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43039348/are-utilities-the-new-tech-why-entergy-nisource-vistra-are-jpmorgans-top-picks-for-2025">named the stock</a> one of the top utility stocks for 2025 earlier this year. The company is scheduled to report fourth-quarter financial results Thursday Feb. 27. Analysts expect the company to report quarterly earnings of $1.14 per share. The company has beat analyst estimates in two straight quarter and four of the last 10 quarters. Analysts expect the company to report quarterly revenue of $3.89 billion. The company has beaten analyst estimates in two of the last three quarters, but missed estimates in seven of the last 10 quarters. Several analyst <a href="https://www.benzinga.com/quote/VST/analyst-ratings">reiterated bullish ratings </a>on the stock in recent weeks with BMO maintaining an Outperform and raising the price target from $151 to $191.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022125&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="999" height="504" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21171749/Screenshot-335.png" alt="" class="wp-image-793865" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21171749/Screenshot-335.png 999w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21171749/Screenshot-335-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21171749/Screenshot-335-768x387.png 768w" sizes="(max-width: 999px) 100vw, 999px" /></a></figure>
Alibaba Group Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>): The large Chinese e-commerce stock saw strong interest over the week thanks to earnings results and increased investments in the artificial intelligence sector. The company <a href="https://www.benzinga.com/news/earnings/25/02/43846533/alibaba-q3-earnings-revenue-and-eps-beat-eyes-global-e-commerce-profitability-in-fy25-increase-investments-in-ai">beat third-quarter </a>revenue and earnings per share estimates. The company has now beaten analyst estimates for earnings per share in nine of the last 10 quarters, while missing revenue estimates in seven of the last 10 quarters. In the quarterly results, Alibaba saw revenue grow across many segments on a year-over-year basis. Alibaba said it expects its international e-commerce unit to be profitable in the next quarter. The company also said it <a href="https://www.benzinga.com/25/02/43874037/alibaba-sees-ai-gold-rush-in-cloud-computing-not-open-and-closed-source-modelshints-monetization-lies-in-powering-ai-not-selling-it">expects to invest</a> more in Cloud and AI in the next three years than in the last decade. Alibaba is focusing on cloud computing as the primary monetization effort for its AI efforts instead of AI models.
Multiple Alibaba analysts<a href="https://www.benzinga.com/quote/BABA/analyst-ratings"> raised their price targets </a>on the stock after the quarterly results, including Benchmark's Fawne Jiang who <a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43888574/alibabas-ai-expansion-e-commerce-growth-reinforce-bullish-analyst-outlook">maintained a Buy rating</a> and raised the target from $118 to $190. Jiang said the company's e-commerce business is rebounding along with the investments in cloud and AI.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022125&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="995" height="506" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21171806/Screenshot-336.png" alt="" class="wp-image-793866" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21171806/Screenshot-336.png 995w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21171806/Screenshot-336-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21171806/Screenshot-336-768x391.png 768w" sizes="(max-width: 995px) 100vw, 995px" /></a></figure>
AptarGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>): The dispensing systems company saw strong interest from Benzinga readers during the week. The company recently reported fourth-quarter financial results with earnings per share beating analyst estimates and revenue missing analyst estimates. The company <a href="https://www.benzinga.com/quote/ATR/analyst-ratings">saw several analysts </a>recently maintain bullish ratings, while lowering their price targets. Given the rising interest in the stock and the $10 billion market capitalization, AptarGroup could be a stock to watch for investors. The stock was up around 2% in the last week and shares are up 5% over the last year.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022125&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="995" height="505" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21171821/Screenshot-337.png" alt="" class="wp-image-793868" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21171821/Screenshot-337.png 995w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21171821/Screenshot-337-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21171821/Screenshot-337-768x390.png 768w" sizes="(max-width: 995px) 100vw, 995px" /></a></figure>
Howmet Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>): The aerospace company recently reported <a href="https://www.benzinga.com/25/02/43697801/howmet-aerospace-q4-revenue-up-92-beats-estimatesprovides-2025-outlook-amid-boeing-and-airbus-uncertainty">fourth-quarter financial results </a>with earnings per share and revenue topping estimates. The company has now beat analyst estimates for earnings per share in eight straight quarters and for revenue in nine of the last 10 quarters. In the quarter, the company saw double-digit growth across many of the reporting segments on a year-over-year basis. Several analysts <a href="https://www.benzinga.com/quote/HWM/analyst-ratings">raised their price targets </a>on the stock after the financial results. Howmet executives said they expect aftermarket growth for spares of 20% to 25% year-over-year in 2025. Executives also cautioned on renegotiations of long-term contracts and the potential tariff impact.
The stock was up slightly during the week and shares are up over 100% in the last year.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022125&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="995" height="502" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21171835/Screenshot-338.png" alt="" class="wp-image-793869" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21171835/Screenshot-338.png 995w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21171835/Screenshot-338-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/21171835/Screenshot-338-768x387.png 768w" sizes="(max-width: 995px) 100vw, 995px" /></a></figure>
Stay tuned for next week&#8217;s report, and follow Benzinga Pro for all the latest headlines and <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022125&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">top market-moving stories here.</a>
Read the latest Stock Whisper Index reports here:
<ul>
<li><a href="https://www.benzinga.com/25/01/43066466/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">January 17</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/25/01/43201590/benzinga-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-2" target="_blank" rel="noreferrer noopener">January 24</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/25/02/43419547/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-52" target="_blank" rel="noreferrer noopener">January 31</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/25/02/43578212/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-53">February 7</a></li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/01/43041374/exclusive-how-high-will-sp-500-go-under-donald-trump-in-2025-readers-are-optimistic-26-say-this" target="_blank" rel="noreferrer noopener">EXCLUSIVE: How High Will S&amp;P 500 Go Under Donald Trump In 2025? Readers Are Optimistic, 26% Say This…</a></li>
</ul>

Exclusives

BABA

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Raymond James analyst Matt Roberts reiterates AptarGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) with a Outperform and lowers the price target from $200 to $190.

Reiteration

Raymond James Reiterates Outperform on AptarGroup, Lowers Price Target to $190

Press Releases

Aptar Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metered-Dose Inhalers

Aptar Declares Quarterly Dividend

Aptar Reports First Quarter 2025 Results

Small Cap

Opinion

Healthcare's Quiet AI Boom Is Creating a New Class of Breakout Contenders

Aptar Releases 2024 Corporate Sustainability Report

Aptar to Participate in Upcoming Investor Conferences

Aptar Named One of the World's Most Sustainable Companies by TIME for Second Consecutive Year

Aptar's Dual-Active Material Science Technology Simultaneously Controls Moisture and Oxygen for Pharmaceutical Drugs and Medical Devices

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

Comments

AptarGroup

Notizie

Ultime notizie per AptarGroup (NYSE:ATR) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO